1. Home
  2. RRC vs RGEN Comparison

RRC vs RGEN Comparison

Compare RRC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Range Resources Corporation

RRC

Range Resources Corporation

HOLD

Current Price

$36.30

Market Cap

8.2B

Sector

Energy

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$140.11

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RRC
RGEN
Founded
1976
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
8.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RRC
RGEN
Price
$36.30
$140.11
Analyst Decision
Hold
Buy
Analyst Count
17
11
Target Price
$41.29
$177.18
AVG Volume (30 Days)
3.2M
700.7K
Earning Date
02-24-2026
02-24-2026
Dividend Yield
1.01%
N/A
EPS Growth
19.84
N/A
EPS
2.38
0.03
Revenue
$2,891,506,000.00
$707,890,000.00
Revenue This Year
$25.70
$17.86
Revenue Next Year
$10.72
$12.44
P/E Ratio
$15.07
$5,478.27
Revenue Growth
24.57
11.74
52 Week Low
$30.32
$102.97
52 Week High
$43.50
$175.77

Technical Indicators

Market Signals
Indicator
RRC
RGEN
Relative Strength Index (RSI) 52.18 29.61
Support Level $35.30 $138.17
Resistance Level $37.29 $146.36
Average True Range (ATR) 1.14 7.10
MACD 0.00 -1.80
Stochastic Oscillator 38.83 8.05

Price Performance

Historical Comparison
RRC
RGEN

About RRC Range Resources Corporation

Fort Worth-based Range Resources is an independent exploration and production company with that focuses entirely on its operations in the Marcellus Shale in Pennsylvania. At year-end 2024, Range Resources' proven reserves totaled 18.1 trillion cubic feet equivalent, with net production of 2.2 billion cubic feet equivalent per day. Natural gas accounted for 68% of production.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: